| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Poliovirus | 28 | 2015 | 47 | 4.550 |
Why?
|
| Cytoplasmic Granules | 13 | 2017 | 51 | 4.510 |
Why?
|
| Protein Biosynthesis | 33 | 2026 | 575 | 4.480 |
Why?
|
| Viral Proteins | 28 | 2017 | 339 | 4.020 |
Why?
|
| Host-Pathogen Interactions | 12 | 2019 | 253 | 3.150 |
Why?
|
| Enterovirus | 10 | 2025 | 52 | 2.610 |
Why?
|
| Cysteine Endopeptidases | 18 | 2014 | 110 | 2.350 |
Why?
|
| Enterovirus Infections | 9 | 2025 | 48 | 2.120 |
Why?
|
| Ribosomes | 13 | 2018 | 124 | 1.870 |
Why?
|
| RNA Recognition Motif Proteins | 8 | 2022 | 19 | 1.800 |
Why?
|
| RNA, Viral | 13 | 2025 | 502 | 1.790 |
Why?
|
| Poly-ADP-Ribose Binding Proteins | 8 | 2022 | 28 | 1.790 |
Why?
|
| RNA Helicases | 9 | 2022 | 75 | 1.760 |
Why?
|
| Virus Replication | 9 | 2019 | 597 | 1.660 |
Why?
|
| Carrier Proteins | 12 | 2017 | 1006 | 1.610 |
Why?
|
| DNA Helicases | 8 | 2022 | 234 | 1.600 |
Why?
|
| RNA, Messenger | 18 | 2026 | 2565 | 1.600 |
Why?
|
| Peptide Initiation Factors | 13 | 2011 | 28 | 1.480 |
Why?
|
| eIF-2 Kinase | 4 | 2015 | 35 | 1.380 |
Why?
|
| Diabetes Mellitus, Type 1 | 12 | 2025 | 877 | 1.380 |
Why?
|
| Stress, Physiological | 6 | 2017 | 260 | 1.370 |
Why?
|
| Poly(A)-Binding Proteins | 9 | 2011 | 23 | 1.330 |
Why?
|
| Poliomyelitis | 8 | 2013 | 17 | 1.210 |
Why?
|
| Virus Diseases | 3 | 2022 | 284 | 1.180 |
Why?
|
| Viruses | 4 | 2016 | 117 | 1.110 |
Why?
|
| Immunity, Innate | 5 | 2022 | 405 | 1.110 |
Why?
|
| Eukaryotic Initiation Factor-4G | 13 | 2026 | 46 | 1.090 |
Why?
|
| HeLa Cells | 27 | 2012 | 698 | 1.080 |
Why?
|
| RNA Viruses | 3 | 2015 | 32 | 1.080 |
Why?
|
| Eukaryotic Initiation Factor-2 | 5 | 2013 | 54 | 1.020 |
Why?
|
| Cytoplasm | 4 | 2019 | 252 | 0.970 |
Why?
|
| Gene Expression Regulation | 7 | 2016 | 2355 | 0.800 |
Why?
|
| Macromolecular Substances | 3 | 2013 | 129 | 0.770 |
Why?
|
| RNA Stability | 3 | 2013 | 75 | 0.770 |
Why?
|
| Proteins | 5 | 2022 | 1015 | 0.760 |
Why?
|
| Insulin-Secreting Cells | 4 | 2021 | 136 | 0.750 |
Why?
|
| RNA | 4 | 2015 | 520 | 0.730 |
Why?
|
| Pancreas | 5 | 2025 | 222 | 0.720 |
Why?
|
| Autoimmunity | 7 | 2025 | 175 | 0.690 |
Why?
|
| Cell Line | 12 | 2022 | 2579 | 0.680 |
Why?
|
| Gene Expression Regulation, Viral | 4 | 2011 | 126 | 0.630 |
Why?
|
| Peptide Fragments | 7 | 2004 | 687 | 0.600 |
Why?
|
| Virus Physiological Phenomena | 2 | 2016 | 12 | 0.590 |
Why?
|
| Jumonji Domain-Containing Histone Demethylases | 1 | 2017 | 31 | 0.520 |
Why?
|
| Casein Kinase II | 1 | 2017 | 12 | 0.510 |
Why?
|
| 5' Untranslated Regions | 5 | 2018 | 57 | 0.510 |
Why?
|
| Enterovirus B, Human | 4 | 2020 | 7 | 0.490 |
Why?
|
| RNA Caps | 6 | 2017 | 28 | 0.480 |
Why?
|
| Endoribonucleases | 2 | 2013 | 88 | 0.470 |
Why?
|
| Apoptosis | 6 | 2017 | 1842 | 0.460 |
Why?
|
| Mengovirus | 1 | 2015 | 3 | 0.450 |
Why?
|
| Humans | 74 | 2026 | 130422 | 0.440 |
Why?
|
| RNA, Double-Stranded | 1 | 2015 | 57 | 0.440 |
Why?
|
| Ribonucleoproteins | 2 | 2012 | 55 | 0.440 |
Why?
|
| Multienzyme Complexes | 2 | 2013 | 76 | 0.430 |
Why?
|
| Caspases | 6 | 2004 | 156 | 0.430 |
Why?
|
| Islets of Langerhans | 3 | 2023 | 161 | 0.420 |
Why?
|
| Eukaryotic Initiation Factors | 2 | 2011 | 36 | 0.420 |
Why?
|
| Eukaryotic Initiation Factor-4E | 4 | 2026 | 58 | 0.410 |
Why?
|
| Trans-Activators | 2 | 2013 | 705 | 0.380 |
Why?
|
| Cell Cycle Proteins | 3 | 2015 | 714 | 0.380 |
Why?
|
| Celiac Disease | 2 | 2025 | 73 | 0.370 |
Why?
|
| RNA-Binding Proteins | 4 | 2011 | 541 | 0.360 |
Why?
|
| Gene Silencing | 2 | 2012 | 230 | 0.360 |
Why?
|
| Models, Biological | 5 | 2020 | 1390 | 0.350 |
Why?
|
| Peptide Hydrolases | 4 | 2005 | 130 | 0.340 |
Why?
|
| Energy Metabolism | 1 | 2016 | 797 | 0.340 |
Why?
|
| Gastrointestinal Microbiome | 3 | 2025 | 837 | 0.340 |
Why?
|
| Animals | 25 | 2026 | 33892 | 0.330 |
Why?
|
| Inhibitor of Apoptosis Proteins | 2 | 2008 | 41 | 0.330 |
Why?
|
| Intestinal Absorption | 2 | 2020 | 170 | 0.310 |
Why?
|
| Nuclear Proteins | 2 | 2015 | 1229 | 0.300 |
Why?
|
| Phosphorylation | 5 | 2017 | 1577 | 0.280 |
Why?
|
| Poly A | 1 | 2008 | 45 | 0.280 |
Why?
|
| Peptide Chain Elongation, Translational | 1 | 2008 | 2 | 0.280 |
Why?
|
| Oxidative Stress | 2 | 2011 | 797 | 0.270 |
Why?
|
| Molecular Sequence Data | 9 | 2008 | 3507 | 0.260 |
Why?
|
| Arsenites | 2 | 2017 | 18 | 0.250 |
Why?
|
| Polyribosomes | 5 | 2010 | 23 | 0.240 |
Why?
|
| Transfection | 5 | 2012 | 961 | 0.240 |
Why?
|
| Protein Binding | 6 | 2026 | 1666 | 0.240 |
Why?
|
| CELF1 Protein | 1 | 2026 | 34 | 0.240 |
Why?
|
| Base Sequence | 8 | 2018 | 2767 | 0.240 |
Why?
|
| Lymphoid Tissue | 1 | 2025 | 48 | 0.220 |
Why?
|
| Blotting, Western | 5 | 2012 | 1019 | 0.220 |
Why?
|
| Glutens | 2 | 2025 | 11 | 0.220 |
Why?
|
| Protein Interaction Mapping | 2 | 2015 | 89 | 0.220 |
Why?
|
| Biocatalysis | 1 | 2024 | 37 | 0.210 |
Why?
|
| Receptor, Fibroblast Growth Factor, Type 1 | 2 | 2018 | 69 | 0.210 |
Why?
|
| Epithelial-Mesenchymal Transition | 1 | 2026 | 252 | 0.210 |
Why?
|
| Software | 2 | 2020 | 737 | 0.210 |
Why?
|
| Cyclopropanes | 1 | 2024 | 67 | 0.210 |
Why?
|
| Capsid Proteins | 2 | 2025 | 148 | 0.210 |
Why?
|
| Autoantibodies | 5 | 2025 | 439 | 0.200 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 1 | 2004 | 168 | 0.200 |
Why?
|
| Biological Assay | 1 | 2004 | 106 | 0.200 |
Why?
|
| Bacteriophages | 1 | 2025 | 97 | 0.200 |
Why?
|
| Antiviral Agents | 2 | 2019 | 806 | 0.200 |
Why?
|
| Feces | 3 | 2025 | 722 | 0.190 |
Why?
|
| Kinetics | 4 | 2010 | 1087 | 0.190 |
Why?
|
| Caspase 3 | 6 | 2004 | 126 | 0.190 |
Why?
|
| Amino Acid Sequence | 8 | 2020 | 2408 | 0.190 |
Why?
|
| Genes, Reporter | 3 | 2010 | 342 | 0.190 |
Why?
|
| Open Reading Frames | 3 | 2010 | 198 | 0.180 |
Why?
|
| Protein Processing, Post-Translational | 4 | 2017 | 361 | 0.170 |
Why?
|
| Mice, Knockout | 3 | 2015 | 3815 | 0.170 |
Why?
|
| Protein Structure, Tertiary | 3 | 2020 | 714 | 0.170 |
Why?
|
| Nucleic Acid Conformation | 3 | 2008 | 180 | 0.170 |
Why?
|
| Signal Transduction | 4 | 2022 | 4674 | 0.170 |
Why?
|
| Cell Line, Tumor | 5 | 2026 | 3715 | 0.170 |
Why?
|
| Interferons | 1 | 2022 | 136 | 0.170 |
Why?
|
| DNA Damage | 1 | 2004 | 513 | 0.170 |
Why?
|
| Biopharmaceutics | 1 | 2020 | 2 | 0.170 |
Why?
|
| Food-Drug Interactions | 1 | 2020 | 10 | 0.170 |
Why?
|
| Bacteria | 1 | 2025 | 536 | 0.160 |
Why?
|
| Anemia, Diamond-Blackfan | 1 | 2020 | 12 | 0.160 |
Why?
|
| Virus Internalization | 1 | 2020 | 58 | 0.160 |
Why?
|
| Ribosomal Proteins | 1 | 2020 | 71 | 0.160 |
Why?
|
| rev Gene Products, Human Immunodeficiency Virus | 1 | 2019 | 15 | 0.160 |
Why?
|
| Hemin | 2 | 1996 | 14 | 0.150 |
Why?
|
| Pharmaceutical Preparations | 1 | 2020 | 78 | 0.150 |
Why?
|
| Leukemia, Erythroblastic, Acute | 2 | 1996 | 12 | 0.150 |
Why?
|
| Repressor Proteins | 3 | 2016 | 774 | 0.150 |
Why?
|
| Cells, Cultured | 4 | 2012 | 2905 | 0.140 |
Why?
|
| Vesicular Transport Proteins | 1 | 2019 | 140 | 0.140 |
Why?
|
| Escherichia coli | 1 | 2024 | 984 | 0.140 |
Why?
|
| Eukaryotic Initiation Factor-4A | 1 | 2018 | 9 | 0.140 |
Why?
|
| DNA Viruses | 1 | 2018 | 30 | 0.140 |
Why?
|
| Information Storage and Retrieval | 1 | 2018 | 64 | 0.140 |
Why?
|
| Arginine | 2 | 2017 | 336 | 0.140 |
Why?
|
| Germ-Line Mutation | 1 | 2020 | 373 | 0.140 |
Why?
|
| Demethylation | 1 | 2017 | 1 | 0.140 |
Why?
|
| Protein Isoforms | 3 | 2005 | 419 | 0.130 |
Why?
|
| Proteolysis | 2 | 2016 | 197 | 0.130 |
Why?
|
| Picornaviridae | 2 | 2005 | 19 | 0.130 |
Why?
|
| Autoimmune Diseases | 1 | 2019 | 264 | 0.130 |
Why?
|
| Protein Interaction Maps | 1 | 2017 | 93 | 0.130 |
Why?
|
| Green Fluorescent Proteins | 2 | 2012 | 369 | 0.130 |
Why?
|
| Wnt Signaling Pathway | 1 | 2018 | 206 | 0.130 |
Why?
|
| Membrane Proteins | 2 | 1995 | 1602 | 0.120 |
Why?
|
| Sequence Analysis, DNA | 2 | 2018 | 1723 | 0.120 |
Why?
|
| Promoter Regions, Genetic | 3 | 2005 | 1227 | 0.120 |
Why?
|
| Proteasome Endopeptidase Complex | 2 | 2010 | 238 | 0.120 |
Why?
|
| Protein Subunits | 1 | 2017 | 160 | 0.120 |
Why?
|
| Genes, Dominant | 1 | 2017 | 245 | 0.120 |
Why?
|
| HIV-1 | 1 | 2019 | 480 | 0.120 |
Why?
|
| Viral Vaccines | 1 | 2019 | 316 | 0.120 |
Why?
|
| Tissue Donors | 3 | 2025 | 502 | 0.120 |
Why?
|
| Ubiquitin-Protein Ligases | 3 | 2010 | 361 | 0.120 |
Why?
|
| Adaptor Proteins, Signal Transducing | 2 | 2014 | 622 | 0.110 |
Why?
|
| Mutation | 4 | 2013 | 6131 | 0.110 |
Why?
|
| Receptors, CCR4 | 1 | 2013 | 7 | 0.100 |
Why?
|
| Cell Membrane | 1 | 2016 | 451 | 0.100 |
Why?
|
| Caliciviridae Infections | 1 | 2017 | 286 | 0.100 |
Why?
|
| Ribonucleases | 1 | 2013 | 41 | 0.100 |
Why?
|
| Immunoblotting | 2 | 2005 | 293 | 0.100 |
Why?
|
| Exoribonucleases | 1 | 2013 | 21 | 0.100 |
Why?
|
| Fluorescent Antibody Technique | 2 | 2011 | 413 | 0.100 |
Why?
|
| Norovirus | 1 | 2017 | 284 | 0.100 |
Why?
|
| Erythroblasts | 1 | 1993 | 4 | 0.100 |
Why?
|
| Enzyme Activation | 2 | 2013 | 582 | 0.100 |
Why?
|
| Insulin | 3 | 2023 | 1146 | 0.100 |
Why?
|
| Transglutaminases | 2 | 2025 | 26 | 0.100 |
Why?
|
| Etoposide | 3 | 2004 | 109 | 0.100 |
Why?
|
| Endopeptidases | 2 | 2000 | 108 | 0.100 |
Why?
|
| Yeasts | 1 | 2013 | 43 | 0.100 |
Why?
|
| Protein Synthesis Inhibitors | 2 | 2011 | 26 | 0.090 |
Why?
|
| DEAD-box RNA Helicases | 1 | 2014 | 159 | 0.090 |
Why?
|
| Proteomics | 1 | 2017 | 610 | 0.090 |
Why?
|
| Jurkat Cells | 2 | 2004 | 85 | 0.090 |
Why?
|
| DNA, Complementary | 2 | 2004 | 431 | 0.090 |
Why?
|
| K562 Cells | 2 | 2004 | 97 | 0.090 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2017 | 613 | 0.090 |
Why?
|
| Child, Preschool | 6 | 2025 | 14985 | 0.090 |
Why?
|
| Virion | 1 | 2012 | 116 | 0.090 |
Why?
|
| Protease Inhibitors | 3 | 2004 | 95 | 0.090 |
Why?
|
| T-Cell Intracellular Antigen-1 | 1 | 2011 | 7 | 0.090 |
Why?
|
| Histidine | 1 | 1992 | 69 | 0.090 |
Why?
|
| Eukaryotic Initiation Factor-3 | 2 | 2010 | 8 | 0.090 |
Why?
|
| RNA Probes | 1 | 2011 | 27 | 0.090 |
Why?
|
| Cysteine | 1 | 1992 | 137 | 0.090 |
Why?
|
| Microscopy, Confocal | 1 | 2012 | 339 | 0.080 |
Why?
|
| Sequence Homology, Nucleic Acid | 2 | 2008 | 256 | 0.080 |
Why?
|
| Longitudinal Studies | 2 | 2025 | 1485 | 0.080 |
Why?
|
| Recombinant Proteins | 2 | 2008 | 1323 | 0.080 |
Why?
|
| In Situ Hybridization | 1 | 2011 | 441 | 0.080 |
Why?
|
| Memory, Long-Term | 1 | 2011 | 36 | 0.080 |
Why?
|
| Luciferases, Firefly | 1 | 2010 | 11 | 0.080 |
Why?
|
| Embryo, Mammalian | 1 | 2012 | 400 | 0.080 |
Why?
|
| Wnt1 Protein | 1 | 2010 | 71 | 0.080 |
Why?
|
| Mammary Tumor Virus, Mouse | 1 | 2010 | 100 | 0.080 |
Why?
|
| Child | 7 | 2025 | 26165 | 0.080 |
Why?
|
| Protein Conformation | 2 | 2008 | 729 | 0.080 |
Why?
|
| Mammary Glands, Human | 1 | 2010 | 79 | 0.080 |
Why?
|
| Cell Nucleus | 2 | 2019 | 569 | 0.080 |
Why?
|
| Polyadenylation | 1 | 2010 | 47 | 0.080 |
Why?
|
| Viral Nonstructural Proteins | 1 | 2010 | 137 | 0.080 |
Why?
|
| Oncogene Proteins | 1 | 2010 | 136 | 0.080 |
Why?
|
| Mice | 4 | 2018 | 18188 | 0.080 |
Why?
|
| Case-Control Studies | 3 | 2023 | 3388 | 0.080 |
Why?
|
| Infant | 5 | 2025 | 13269 | 0.070 |
Why?
|
| Plasmids | 2 | 2005 | 451 | 0.070 |
Why?
|
| Mammary Neoplasms, Experimental | 1 | 2010 | 235 | 0.070 |
Why?
|
| Catalysis | 2 | 2004 | 137 | 0.070 |
Why?
|
| Surveys and Questionnaires | 1 | 2018 | 4002 | 0.070 |
Why?
|
| Administration, Oral | 2 | 2020 | 695 | 0.070 |
Why?
|
| Peptide Termination Factors | 1 | 2008 | 16 | 0.070 |
Why?
|
| Baculoviral IAP Repeat-Containing 3 Protein | 1 | 2008 | 4 | 0.070 |
Why?
|
| Thapsigargin | 1 | 2008 | 20 | 0.070 |
Why?
|
| Fibroblasts | 1 | 2012 | 857 | 0.070 |
Why?
|
| Viral Interference | 1 | 2007 | 6 | 0.070 |
Why?
|
| DNA, Recombinant | 1 | 2008 | 71 | 0.070 |
Why?
|
| Cisplatin | 2 | 2000 | 271 | 0.070 |
Why?
|
| Metagenomics | 2 | 2019 | 115 | 0.070 |
Why?
|
| RNA, Ribosomal | 1 | 2008 | 52 | 0.070 |
Why?
|
| Vertebrates | 1 | 2008 | 36 | 0.070 |
Why?
|
| Female | 9 | 2026 | 70285 | 0.070 |
Why?
|
| Hydrolysis | 2 | 2000 | 139 | 0.070 |
Why?
|
| HIV Infections | 1 | 2019 | 2013 | 0.070 |
Why?
|
| Male | 9 | 2025 | 64527 | 0.060 |
Why?
|
| Rabbits | 3 | 2008 | 574 | 0.060 |
Why?
|
| Nucleic Acid Synthesis Inhibitors | 2 | 2004 | 11 | 0.060 |
Why?
|
| Binding Sites | 3 | 2002 | 1149 | 0.060 |
Why?
|
| Endoplasmic Reticulum | 1 | 2008 | 209 | 0.060 |
Why?
|
| Adolescent | 5 | 2025 | 20754 | 0.060 |
Why?
|
| Tumor Cells, Cultured | 3 | 2000 | 985 | 0.060 |
Why?
|
| Poly(A)-Binding Protein I | 1 | 2026 | 6 | 0.060 |
Why?
|
| Cell Extracts | 2 | 2004 | 14 | 0.060 |
Why?
|
| 3' Untranslated Regions | 1 | 2026 | 155 | 0.060 |
Why?
|
| Models, Genetic | 1 | 2008 | 748 | 0.060 |
Why?
|
| Codon | 1 | 2005 | 93 | 0.060 |
Why?
|
| Luciferases | 1 | 2005 | 126 | 0.060 |
Why?
|
| Insecta | 1 | 2005 | 50 | 0.060 |
Why?
|
| Immunoprecipitation | 1 | 2005 | 192 | 0.050 |
Why?
|
| Caliciviridae | 1 | 2004 | 11 | 0.050 |
Why?
|
| Fatty Acid Synthases | 1 | 2024 | 12 | 0.050 |
Why?
|
| Methane | 1 | 2024 | 17 | 0.050 |
Why?
|
| Reticulocytes | 1 | 2004 | 31 | 0.050 |
Why?
|
| Stereoisomerism | 1 | 2024 | 109 | 0.050 |
Why?
|
| Leupeptins | 1 | 2004 | 21 | 0.050 |
Why?
|
| Receptors, Virus | 2 | 1995 | 95 | 0.050 |
Why?
|
| Transcription, Genetic | 2 | 2005 | 1391 | 0.050 |
Why?
|
| Insulin Antibodies | 1 | 2023 | 7 | 0.050 |
Why?
|
| Metagenome | 1 | 2025 | 142 | 0.050 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 2004 | 256 | 0.050 |
Why?
|
| Catalytic Domain | 1 | 2004 | 159 | 0.050 |
Why?
|
| Methyltransferases | 1 | 2024 | 78 | 0.050 |
Why?
|
| Glutamate Decarboxylase | 1 | 2023 | 44 | 0.050 |
Why?
|
| Alternative Splicing | 1 | 2005 | 310 | 0.050 |
Why?
|
| RNA Cap-Binding Proteins | 3 | 1988 | 5 | 0.050 |
Why?
|
| RNA Splicing | 1 | 2004 | 237 | 0.050 |
Why?
|
| Codon, Initiator | 1 | 2002 | 8 | 0.050 |
Why?
|
| Exons | 1 | 2005 | 764 | 0.050 |
Why?
|
| RNA Interference | 1 | 2004 | 494 | 0.050 |
Why?
|
| Environmental Exposure | 1 | 2025 | 288 | 0.050 |
Why?
|
| Subcellular Fractions | 1 | 2002 | 90 | 0.050 |
Why?
|
| Luminescent Proteins | 1 | 2002 | 145 | 0.050 |
Why?
|
| Cell Survival | 2 | 1995 | 837 | 0.050 |
Why?
|
| Time Factors | 2 | 2018 | 6190 | 0.050 |
Why?
|
| Gene Deletion | 1 | 2005 | 769 | 0.040 |
Why?
|
| DNA | 2 | 2005 | 1419 | 0.040 |
Why?
|
| Eukaryotic Cells | 1 | 2001 | 29 | 0.040 |
Why?
|
| Down-Regulation | 1 | 2004 | 655 | 0.040 |
Why?
|
| Fatty Acids | 1 | 2024 | 377 | 0.040 |
Why?
|
| Phosphoproteins | 1 | 2004 | 454 | 0.040 |
Why?
|
| Madin Darby Canine Kidney Cells | 1 | 2020 | 10 | 0.040 |
Why?
|
| Machine Learning | 1 | 2025 | 385 | 0.040 |
Why?
|
| Drug Liberation | 1 | 2020 | 43 | 0.040 |
Why?
|
| Chemistry, Pharmaceutical | 1 | 2020 | 51 | 0.040 |
Why?
|
| Young Adult | 2 | 2025 | 9995 | 0.040 |
Why?
|
| Solubility | 1 | 2020 | 117 | 0.040 |
Why?
|
| Peptide Chain Initiation, Translational | 1 | 2000 | 14 | 0.040 |
Why?
|
| Permeability | 1 | 2020 | 119 | 0.040 |
Why?
|
| Guanosine Diphosphate | 1 | 2000 | 12 | 0.040 |
Why?
|
| Penetrance | 1 | 2020 | 109 | 0.040 |
Why?
|
| RNA Transport | 1 | 2019 | 8 | 0.040 |
Why?
|
| HLA-DQ Antigens | 1 | 2019 | 22 | 0.040 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2002 | 694 | 0.040 |
Why?
|
| Infant, Newborn | 2 | 2025 | 8493 | 0.040 |
Why?
|
| Serine Endopeptidases | 1 | 2020 | 196 | 0.040 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2020 | 409 | 0.040 |
Why?
|
| Karyopherins | 1 | 2019 | 35 | 0.040 |
Why?
|
| Dogs | 1 | 2020 | 615 | 0.040 |
Why?
|
| Disease Models, Animal | 1 | 2010 | 4656 | 0.040 |
Why?
|
| GTP-Binding Proteins | 1 | 2019 | 160 | 0.040 |
Why?
|
| Deoxyadenine Nucleotides | 1 | 1998 | 6 | 0.040 |
Why?
|
| Amino Acid Chloromethyl Ketones | 1 | 1998 | 10 | 0.040 |
Why?
|
| Cytochrome c Group | 1 | 1998 | 13 | 0.040 |
Why?
|
| Forecasting | 1 | 2020 | 353 | 0.040 |
Why?
|
| Burkitt Lymphoma | 1 | 2000 | 132 | 0.040 |
Why?
|
| Pets | 1 | 2018 | 19 | 0.040 |
Why?
|
| Biological Specimen Banks | 1 | 2019 | 63 | 0.040 |
Why?
|
| Risk Factors | 2 | 2025 | 10942 | 0.040 |
Why?
|
| Protein Transport | 1 | 2019 | 363 | 0.040 |
Why?
|
| Datasets as Topic | 1 | 2018 | 100 | 0.040 |
Why?
|
| Triterpenes | 1 | 2018 | 23 | 0.040 |
Why?
|
| Cell Differentiation | 2 | 1996 | 1925 | 0.030 |
Why?
|
| Oligopeptides | 1 | 1998 | 105 | 0.030 |
Why?
|
| Benzofurans | 1 | 2018 | 33 | 0.030 |
Why?
|
| Bifidobacterium | 1 | 2018 | 65 | 0.030 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2020 | 528 | 0.030 |
Why?
|
| Adaptive Immunity | 1 | 2019 | 100 | 0.030 |
Why?
|
| Genome, Viral | 1 | 2018 | 159 | 0.030 |
Why?
|
| Siblings | 1 | 2018 | 202 | 0.030 |
Why?
|
| Cluster Analysis | 1 | 2018 | 417 | 0.030 |
Why?
|
| Computer Simulation | 1 | 2020 | 676 | 0.030 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 1 | 2019 | 325 | 0.030 |
Why?
|
| RNA, Ribosomal, 16S | 1 | 2018 | 386 | 0.030 |
Why?
|
| Adenoviridae | 1 | 2019 | 583 | 0.030 |
Why?
|
| Breast Feeding | 1 | 2018 | 229 | 0.030 |
Why?
|
| Isotope Labeling | 1 | 2017 | 94 | 0.030 |
Why?
|
| Pedigree | 1 | 2020 | 1683 | 0.030 |
Why?
|
| Heat Stress Disorders | 1 | 1996 | 10 | 0.030 |
Why?
|
| Transcriptome | 1 | 2023 | 1129 | 0.030 |
Why?
|
| Protein-Arginine N-Methyltransferases | 1 | 2016 | 35 | 0.030 |
Why?
|
| Cohort Studies | 1 | 2025 | 5069 | 0.030 |
Why?
|
| Molecular Weight | 2 | 1987 | 280 | 0.030 |
Why?
|
| Gene Expression | 1 | 2020 | 1493 | 0.030 |
Why?
|
| Methylation | 1 | 2016 | 197 | 0.030 |
Why?
|
| DNA-Binding Proteins | 1 | 2004 | 1972 | 0.030 |
Why?
|
| Databases, Genetic | 1 | 2018 | 507 | 0.030 |
Why?
|
| Major Histocompatibility Complex | 1 | 1995 | 49 | 0.030 |
Why?
|
| Clinical Trials as Topic | 1 | 2020 | 1125 | 0.030 |
Why?
|
| Milk, Human | 1 | 2018 | 312 | 0.030 |
Why?
|
| Intestinal Mucosa | 1 | 2020 | 765 | 0.030 |
Why?
|
| Blotting, Northern | 1 | 1995 | 236 | 0.030 |
Why?
|
| Databases, Factual | 1 | 2020 | 1223 | 0.030 |
Why?
|
| Biomarkers | 1 | 2025 | 3394 | 0.030 |
Why?
|
| Mass Spectrometry | 1 | 2017 | 362 | 0.030 |
Why?
|
| Histocompatibility Antigens Class I | 1 | 1995 | 110 | 0.030 |
Why?
|
| Middle Aged | 2 | 2025 | 28383 | 0.030 |
Why?
|
| Hemoglobins | 1 | 1995 | 288 | 0.030 |
Why?
|
| Colorectal Neoplasms | 1 | 2020 | 623 | 0.030 |
Why?
|
| Interferon-Induced Helicase, IFIH1 | 1 | 2014 | 13 | 0.030 |
Why?
|
| Adult | 2 | 2025 | 31127 | 0.030 |
Why?
|
| Receptors, Retinoic Acid | 1 | 2014 | 77 | 0.030 |
Why?
|
| Vaccination | 1 | 2019 | 1041 | 0.030 |
Why?
|
| Cytopathogenic Effect, Viral | 1 | 1993 | 27 | 0.020 |
Why?
|
| Eukaryotic Initiation Factor-4F | 1 | 1993 | 8 | 0.020 |
Why?
|
| Adsorption | 1 | 1993 | 32 | 0.020 |
Why?
|
| Flow Cytometry | 1 | 1995 | 767 | 0.020 |
Why?
|
| Diet | 1 | 2019 | 1098 | 0.020 |
Why?
|
| Neutralization Tests | 1 | 1993 | 226 | 0.020 |
Why?
|
| Disulfides | 1 | 1992 | 60 | 0.020 |
Why?
|
| Cell Division | 1 | 1993 | 721 | 0.020 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 1992 | 302 | 0.020 |
Why?
|
| Cysteine Proteinase Inhibitors | 1 | 1991 | 34 | 0.020 |
Why?
|
| Neoplasm Proteins | 1 | 1995 | 683 | 0.020 |
Why?
|
| Metals | 1 | 1992 | 67 | 0.020 |
Why?
|
| Oligonucleotides | 1 | 1991 | 96 | 0.020 |
Why?
|
| F-Box-WD Repeat-Containing Protein 7 | 1 | 2010 | 20 | 0.020 |
Why?
|
| Antineoplastic Agents | 1 | 2000 | 1796 | 0.020 |
Why?
|
| Substrate Specificity | 1 | 1991 | 285 | 0.020 |
Why?
|
| F-Box Proteins | 1 | 2010 | 32 | 0.020 |
Why?
|
| Sequence Alignment | 1 | 1992 | 585 | 0.020 |
Why?
|
| Ligands | 1 | 1992 | 486 | 0.020 |
Why?
|
| Amygdala | 1 | 2011 | 76 | 0.020 |
Why?
|
| DNA, Viral | 1 | 1992 | 452 | 0.020 |
Why?
|
| Receptor, Fibroblast Growth Factor, Type 2 | 1 | 2010 | 37 | 0.020 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2020 | 1443 | 0.020 |
Why?
|
| Immunoenzyme Techniques | 1 | 2010 | 236 | 0.020 |
Why?
|
| United States | 1 | 2025 | 11827 | 0.020 |
Why?
|
| DNA Mutational Analysis | 1 | 1991 | 788 | 0.020 |
Why?
|
| Nuclear Receptor Coactivator 3 | 1 | 2010 | 258 | 0.020 |
Why?
|
| Aphthovirus | 1 | 1988 | 3 | 0.020 |
Why?
|
| beta Catenin | 1 | 2010 | 199 | 0.020 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2019 | 3425 | 0.020 |
Why?
|
| Neuronal Plasticity | 1 | 2011 | 291 | 0.020 |
Why?
|
| Rhinovirus | 1 | 2008 | 66 | 0.020 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2011 | 1111 | 0.020 |
Why?
|
| Cell-Free System | 1 | 1987 | 62 | 0.020 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2010 | 1215 | 0.020 |
Why?
|
| Cloning, Molecular | 1 | 1988 | 781 | 0.020 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2010 | 1004 | 0.020 |
Why?
|
| Antibodies, Viral | 1 | 1993 | 1167 | 0.020 |
Why?
|
| Antigen-Antibody Complex | 1 | 1986 | 52 | 0.020 |
Why?
|
| Rats | 1 | 2011 | 3397 | 0.010 |
Why?
|
| Caspase Inhibitors | 1 | 2004 | 31 | 0.010 |
Why?
|
| DNA-Activated Protein Kinase | 1 | 2004 | 28 | 0.010 |
Why?
|
| Gene Expression Profiling | 1 | 2010 | 1827 | 0.010 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2010 | 2024 | 0.010 |
Why?
|
| Biomarkers, Tumor | 1 | 2010 | 1606 | 0.010 |
Why?
|
| RNA Processing, Post-Transcriptional | 1 | 2001 | 67 | 0.010 |
Why?
|
| RNA, Transfer | 1 | 2001 | 67 | 0.010 |
Why?
|
| Enzyme Inhibitors | 1 | 2004 | 567 | 0.010 |
Why?
|
| Genes | 1 | 2001 | 310 | 0.010 |
Why?
|
| Artifacts | 1 | 2001 | 104 | 0.010 |
Why?
|
| Cycloheximide | 1 | 2000 | 42 | 0.010 |
Why?
|
| Genetic Vectors | 1 | 2001 | 902 | 0.010 |
Why?
|
| Cell Cycle | 1 | 2000 | 600 | 0.010 |
Why?
|
| Research Design | 1 | 2001 | 718 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 2001 | 2919 | 0.010 |
Why?
|
| Sulfhydryl Compounds | 1 | 1992 | 54 | 0.010 |
Why?
|